investorscraft@gmail.com

Intrinsic ValueEmeis (EMEIS.PA)

Previous Close13.62
Intrinsic Value
Upside potential
Previous Close
13.62

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Emeis operates as a leading provider of healthcare services across Europe and select international markets, specializing in nursing homes, assisted-living facilities, post-acute rehabilitation, and psychiatric hospitals. The company generates revenue through a mix of private pay and government-funded healthcare contracts, leveraging its extensive network of facilities to deliver personalized care for elderly and specialized patient populations. Its diversified service offerings include accommodation, therapeutic workshops, and home care assistance, ensuring recurring revenue streams. Emeis holds a strong market position in France, where it was founded, and has expanded into Belgium, Spain, Italy, and beyond, capitalizing on aging demographics and increasing demand for long-term care. The company differentiates itself through integrated care models, combining medical expertise with residential services, which enhances patient outcomes and operational efficiency. Despite regulatory pressures in some markets, Emeis maintains a competitive edge through scale, geographic diversification, and a reputation for quality care. Its expansion into post-acute rehabilitation and psychiatric services further strengthens its resilience against sector-specific risks.

Revenue Profitability And Efficiency

In FY 2023, Emeis reported revenue of €5.20 billion, reflecting its broad service footprint and stable demand for healthcare services. Net income stood at €1.35 billion, with diluted EPS of €130.59, indicating robust profitability. Operating cash flow was €366.1 million, though capital expenditures of €141.0 million suggest ongoing investments in facility maintenance and expansion. The company’s ability to convert revenue into earnings underscores its operational efficiency.

Earnings Power And Capital Efficiency

Emeis demonstrates strong earnings power, supported by high-margin specialized care services and government-backed reimbursement structures. The company’s capital efficiency is evident in its ability to sustain profitability despite significant debt levels, though leverage remains a focus area. Its asset-light model in home care services contributes to higher returns on invested capital compared to pure-play facility operators.

Balance Sheet And Financial Health

Emeis’s balance sheet shows €645.0 million in cash and equivalents against total debt of €9.16 billion, highlighting a leveraged position common in capital-intensive healthcare operators. The absence of dividends suggests prioritization of debt management and reinvestment. While the debt load is substantial, the company’s recurring revenue streams provide stability for servicing obligations.

Growth Trends And Dividend Policy

Growth is driven by demographic trends favoring elderly care demand, with expansion into new markets like Latin America and China. Emeis does not currently pay dividends, opting to retain earnings for debt reduction and strategic acquisitions. Future growth may hinge on regulatory environments and the scalability of its home care segment.

Valuation And Market Expectations

With a market cap of €1.67 billion and a beta of 0.77, Emeis is viewed as a relatively stable investment within healthcare. The market appears to price in steady cash flows but remains cautious about leverage and regulatory risks. Valuation multiples likely reflect its niche positioning and long-term growth potential in aging societies.

Strategic Advantages And Outlook

Emeis benefits from geographic diversification, a diversified care portfolio, and entrenched relationships with public healthcare systems. Near-term challenges include managing debt and adapting to regulatory changes, but long-term demand for its services remains structurally supported. The company’s focus on integrated care models positions it well for sustainable growth.

Sources

Company description, financial data from disclosed filings, and market cap from exchange data.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount